WASHINGTON - Texas Children’s Hospital has become the first paediatric hospital in the US to discharge a child while on an intracorporeal ventricular assist device (VAD), a feat previously accomplished only at adult institutions.
The patient, 16-year-old Francisco “Frank” De Santiago, who was implanted with a mechanical heart pump called the HeartMate II on May 19, 2009, was discharged on Oct. 29, 2009.
“This is a promising next step for the care of children with heart failure as Frank is the first patient on record to be medically discharged from a pediatric hospital with a mechanical heart assist device. The device, which is implanted into the chest cavity near the heart, stays inside the body rather than outside. It has helped the patient grow stronger by allowing him to eat well, exercise and enjoy life,” said Dr. David L.S. Morales, paediatric cardiovascular surgeon at Texas Children’s Heart Center, who performed the surgery on De Santiago.
Texas Children’s Hospital is the first paediatric hospital in the world to use the HeartMate II.
Since April, 2008, Morales, Director of the Pediatric Mechanical Circulatory Support Program, has implanted five teen and pre-teen patients, including De Santiago, with VADs.
Four of these patients have already received successful heart transplants and are enjoying their teen years in good health.
“What’s especially significant about De Santiago’s case is that his life outside the hospital signals a new era of possibilities for pediatric heart failure patients, especially as the number of cases diagnosed annually continues to rise. Until now, pediatric hospitals have kept patients in the hospital, if not the ICU, while awaiting transplant,” said Morales.
The Thoratec HeartMate II, about the size of two “D” cell batteries laid end-to-end, received U. S. Food and Drug Administration approval on April 26, 2008.
The pump is a long-term, mechanical circulatory support device designed for a broad range of advanced-stage heart failure patients.
It allowed paediatric patients to live until a donor heart becomes available.
The device could also allow some of these children to recover their heart function.
De Santiago was flown to Texas Children’s Hospital in May after having suffered a temporary stroke.
He was diagnosed with dilated cardiomyopathy, a condition in which his heart was enlarged to more than twice a normal size and could not pump blood efficiently.
Physicians placed him on a heart transplant list and decided to implant a HeartMate II.
Morales said that De Santiago is able to enjoy a more normal life outside the hospital.
“He can do many of the things he loves like eating his mother’s home cooking, exercising outdoors and going to the movies. He’ll be coming to Texas Children’s for follow-up visits and physical therapy. We’re keeping a close eye on him while he waits for a donor heart,” Morales said. (ANI)
Related News
Teen forced to shoot polar bear after getting trapped on ice floe in Canadian ArcticNovember 9th, 2009 Canadian teen rescued on Arctic iceCORAL HARBOUR, Nunavut — Battling hypothermia, a 17-year-old hunter stranded on a floating chunk of ice shot and killed a polar bear while trapped for more than a day before being rescued Monday in the Canadian Arctic. The teen and his 67-year-old uncle, who were polar bear hunting, were reported missing late Saturday, Ed Zebedee, director of the Government of Nunavut's protection services branch, said Monday.
FDA panel rejects Zimmer spine repair device on questions of safety and effectivenessNovember 4th, 2009 FDA panel rejects Zimmer spine implantGAITHERSBURG, Md. — Federal health advisers on Wednesday rejected an implant from Zimmer Holdings saying it's unclear how effective or safe the device would be for treating a painful spinal condition.
Health regulators probe influence of financial payments on Zimmer spinal implant studyNovember 2nd, 2009 FDA questions role of payments in Zimmer studyWASHINGTON — Federal health officials say an implant from Zimmer Holdings Inc. appears to be effective in treating spinal problems, but questions remain about whether company payments to doctors influenced the device's trial data.
Giving oxygen to H1N1 patients with respiratory failure improves survivalOctober 13th, 2009 WASHINGTON - A new study has revealed that adding oxygen to the blood of H1N1 patients suffering from respiratory failure can significantly improve their survival. The researchers said that patients who developed severe acute respiratory distress syndrome (ARDS), were treated with extracorporeal membrane oxygenation (ECMO).
Old woman dies during hospital power cut, government orders probeOctober 11th, 2009 NEW DELHI - The Delhi government Sunday ordered a probe into the death of 74-year-old Sharda Gaur, who died Saturday when her life support device failed during a power cut in a government hospital. Gaur was admitted to the Govind Ballabh Pant Hospital in New Delhi area Sep 7.
Implanted cardiac defibrillator credited with saving the life of 61-year-old man shot in chestOctober 7th, 2009 Defibrillator saves man who was shot in the chestMINNEAPOLIS — A defibrillator was credited with stopping a bullet in the chest of a gunshot victim. Doctors in Florida said the 61-year-old unidentified man had an Medtronic implantable cardiac defibrillator to prevent sudden cardiac arrest.
Institute of Medicine will review FDA's system for clearing low-risk medical devicesSeptember 23rd, 2009 FDA medical device approvals get external reviewWASHINGTON — The Food and Drug Administration is asking the government's top medical advisers to review its system for approving certain types of medical devices that has been criticized by safety advocates and government watchdogs. The Institute of Medicine will study FDA's so-called 510k review procedure, which allows device companies to immediately launch products similar to those already on the market.
Nanotech-magnetism combo leads to tiny implantable device for drug deliverySeptember 20th, 2009 WASHINGTON - Combining magnetism with nanotechnology, researchers have developed a small implantable device that can be repeatedly turned on and off to deliver and adjust doses of medications inside a patient's body. Dr. Daniel Kohane, of Children's Hospital Boston, has revealed that the tiny device encapsulates the drug in a specially engineered membrane, embedded with nanoparticles composed of magnetite, a mineral with natural magnetic properties.
Wireless pacemakers can keep heart patients in touch with docsSeptember 11th, 2009 WASHINGTON - American doctors have implanted one of the first wireless pacemakers in the country. Dr. Rick Henderson, an electrophysiologist at Wake Forest University Baptist Medical Center's Heart Center, has revealed that the new wireless pacemakers transmit additional information about the patient's heart with greater frequency.
Fla. man accused of impersonating a police officer allegedly asks teen to take urine testSeptember 10th, 2009 Alleged fake cop asks teen to take urine testPENSACOLA, Fla. — Authorities said they have arrested a 30-year-old Pensacola man for impersonating a law enforcement officer.
New therapy to prevent heart failureSeptember 2nd, 2009 LONDON - A new study has found that cardiac resynchronization device combined with the defibrillator (CRT-D) can significantly reduce death risk and heart failure in cardiac patients. The researchers found that patients who had a cardiac resynchronization had a 34 percent reduction in their risk of death or heart failure.
New therapy shows promise for heart failure patientsSeptember 1st, 2009 LONDON - A major international study has found that a therapy called cardiac resynchronization can significantly delay the progression of heart failure. In the study, researchers found that the treatment reduced the risk of serious heart failure events by 41 percent.
'Resynchronisation' cuts down risk of heart failuresSeptember 1st, 2009 WASHINGTON - A therapy called cardiac 'resynchronisation' reduced risk of heart failures by 41 percent, says an international study. "This shows, for the first time, that the onset of heart failure symptoms and hospitalisation for heart failure can be delayed with pacing therapy," said David Wilber, director of the Cardiovascular Institute at Loyola University (Chicago) Stritch School of Medicine.
Abiomed says first patient implanted with heart replacement died after about 10 weeksSeptember 1st, 2009 Abiomed says first AbioCor heart patient has diedDANVERS, Mass. — Abiomed Inc.
Study: Combination heart device cut patients' chances of heart failure by 41 percentSeptember 1st, 2009 Combination heart device reduced heart failureBARCELONA, Spain — A two-in-one heart device to fix irregular beats and contraction patterns cut patients' chances of developing heart failure by 41 percent, new research says. While the device spared many patients from going to the hospital, it made no difference in saving lives, and some doctors say they won't rush to implant more patients with the pricey devices.
